Formulary Chapter 6: Endocrine system - Full Chapter
|
Dydrogesterone (Duphaston®)
|
Non Formulary
|
|
Dysrogesterone (Duphaston® HRT)
|
Non Formulary
|
|
Norethisterone (Micronor®HRT)
|
Non Formulary
|
|
Progesterone Injection (Gestone®)
|
Non Formulary
|
|
Ulipristal acetate (Esmya®)
|
Non Formulary
|
MHRA March 2020 Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury
July 2018 - Traffic light status amended to RED in light of EMA update
Esmya: new measures to minimise risk of rare but serious liver injury
The only indication approved for use by the APC is pre-operative treatment of moderate to severe symptoms of uterine fibroids (1 course). |
Key |
|
Restricted Drug |
|
Unlicensed |
|
Link to adult BNF
|
|
Link to children's BNF
|
|
Link to SPCs
|
|
Cytotoxic Drug |
|
Controlled Drug |
|
|
High Cost Medicine |
|
Cancer Drugs Fund |
|
NHS England |
|
Homecare |
|
ICB |
|
Low carbon footprint |
|
Medium carbon footprint |
|
High carbon footprint |
|
Status |
Description |
|
Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications |
|
Amber Specialist Initiation: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate. This may be supported by a RICaD, annotated within the formulary entry. |
|
Amber Shared Care: Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing, in accordance with an ESCA, annotated within the formulary entry. |
|
Amber Specialist Recommendation: Initiation and maintenance of prescribing in Primary Care following recommendation from a specialist. |
|
Medicines for initiation and maintenance prescribing by Specialists (hospital or GPs with Special Interest) only |
|
Positive NICE TA and /or awaiting local clarification on place in therapy; Please contact your Medicines Optimisation team for more information. |
|
Non-formulary Medicines which APC/Trust DTC has actively reviewed and do not recommend for use. |
|
Check Notes as varies across the area |
|
|